凝集素补体途径会将川崎病和新型冠状病毒肺炎联系起来吗？ - Suppr

Suppr

超能文献

Does the Lectin Complement Pathway Link Kawasaki Disease and SARS-CoV-2?

作者信息

Polycarpou Anastasia, Grigoriadou Sofia, Klavinskis Linda, Sacks Steven

机构信息

School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.

Immunology Department, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.

出版信息

Front Immunol. 2021 Jan 14;11:604512. doi: 10.3389/fimmu.2020.604512. eCollection 2020.

DOI:10.3389/fimmu.2020.604512

PMID:33584675

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7874141/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad40/7874141/13964191de85/fimmu-11-604512-g001.jpg

相似文献

Does the Lectin Complement Pathway Link Kawasaki Disease and SARS-CoV-2?

Front Immunol. 2021 Jan 14;11:604512. doi: 10.3389/fimmu.2020.604512. eCollection 2020.

CD64, CD11a and CD18 leukocytes expression in children with SARS-CoV-2 multisystem inflammatory syndrome versus children with Kawasaki disease: Similar but not the same.

Med Clin (Barc). 2021 Jan 22;156(2):89-91. doi: 10.1016/j.medcli.2020.09.002. Epub 2020 Sep 25.

Characterization of SARS-CoV-2 and common cold coronavirus-specific T-cell responses in MIS-C and Kawasaki disease children.

Eur J Immunol. 2022 Jan;52(1):123-137. doi: 10.1002/eji.202149556. Epub 2021 Oct 27.

Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).

Pediatrics. 2020 Dec;146(6). doi: 10.1542/peds.2020-018242. Epub 2020 Sep 2.

Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease.

Curr Rheumatol Rep. 2021 Jul 3;23(8):58. doi: 10.1007/s11926-021-01028-4.

Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.

Front Immunol. 2021 Feb 26;12:632890. doi: 10.3389/fimmu.2021.632890. eCollection 2021.

Prevalence of paediatric hyperinflammatory conditions in paediatric and adolescent hospitalized COVID-19 patients: a systematic review and meta-analysis.

APMIS. 2022 Feb;130(2):101-110. doi: 10.1111/apm.13199. Epub 2021 Dec 22.

The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection.

Expert Rev Clin Immunol. 2020 Dec;16(12):1205-1215. doi: 10.1080/1744666X.2021.1847643. Epub 2020 Nov 25.

J Clin Invest. 2021 Mar 15;131(6). doi: 10.1172/JCI144554.

The emergence of a new cytokine storm during the COVID-19 pandemic: Multisystem inflammatory syndrome in children.

Kaohsiung J Med Sci. 2021 Mar;37(3):255-256. doi: 10.1002/kjm2.12347. Epub 2021 Jan 5.

引用本文的文献

Plasma Exosomal-Derived SERPINA1 and GNAI2 Downregulation as Potential Diagnostic Biomarkers of Kawasaki Disease with Coronary Artery Aneurysms.

Int J Mol Sci. 2025 Mar 16;26(6):2668. doi: 10.3390/ijms26062668.

[Berberine ameliorates coronary artery endothelial cell injury in Kawasaki disease through complement and coagulation cascades].

Zhongguo Dang Dai Er Ke Za Zhi. 2025 Jan 15;27(1):101-108. doi: 10.7499/j.issn.1008-8830.2406075.

Reduction in ACE2 expression in peripheral blood mononuclear cells during COVID-19 - implications for post COVID-19 conditions.

BMC Infect Dis. 2024 Jul 3;24(1):663. doi: 10.1186/s12879-024-09321-0.

Immunology of Multisystem Inflammatory Syndrome after COVID-19 in Children: A Review of the Current Evidence.

Int J Mol Sci. 2023 Mar 16;24(6):5711. doi: 10.3390/ijms24065711.

Mechanisms of Immune Dysregulation in COVID-19 Are Different From SARS and MERS: A Perspective in Context of Kawasaki Disease and MIS-C.

Front Pediatr. 2022 May 5;10:790273. doi: 10.3389/fped.2022.790273. eCollection 2022.

Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison.

Nat Rev Rheumatol. 2021 Dec;17(12):731-748. doi: 10.1038/s41584-021-00709-9. Epub 2021 Oct 29.

The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery.

iScience. 2021 Nov 19;24(11):103215. doi: 10.1016/j.isci.2021.103215. Epub 2021 Oct 2.

本文引用的文献

The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series.

Br J Dermatol. 2021 Jan;184(1):141-150. doi: 10.1111/bjd.19415. Epub 2020 Sep 15.

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents.

N Engl J Med. 2020 Jul 23;383(4):334-346. doi: 10.1056/NEJMoa2021680. Epub 2020 Jun 29.

Multisystem Inflammatory Syndrome in Children in New York State.

N Engl J Med. 2020 Jul 23;383(4):347-358. doi: 10.1056/NEJMoa2021756. Epub 2020 Jun 29.

Rationale for targeting complement in COVID-19.

EMBO Mol Med. 2020 Aug 7;12(8):e12642. doi: 10.15252/emmm.202012642. Epub 2020 Jul 12.

Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.

JAMA. 2020 Jul 21;324(3):259-269. doi: 10.1001/jama.2020.10369.

Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City.

JAMA. 2020 Jul 21;324(3):294-296. doi: 10.1001/jama.2020.10374.

Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study.

BMJ. 2020 Jun 3;369:m2094. doi: 10.1136/bmj.m2094.

An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.

Lancet. 2020 Jun 6;395(10239):1771-1778. doi: 10.1016/S0140-6736(20)31103-X. Epub 2020 May 13.

Hyperinflammatory shock in children during COVID-19 pandemic.

Lancet. 2020 May 23;395(10237):1607-1608. doi: 10.1016/S0140-6736(20)31094-1. Epub 2020 May 7.

Site-specific glycan analysis of the SARS-CoV-2 spike.

Science. 2020 Jul 17;369(6501):330-333. doi: 10.1126/science.abb9983. Epub 2020 May 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Does the Lectin Complement Pathway Link Kawasaki Disease and SARS-CoV-2?

作者信息

Polycarpou Anastasia, Grigoriadou Sofia, Klavinskis Linda, Sacks Steven

机构信息

School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.

Immunology Department, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.

出版信息

Front Immunol. 2021 Jan 14;11:604512. doi: 10.3389/fimmu.2020.604512. eCollection 2020.

DOI:10.3389/fimmu.2020.604512

PMID:33584675

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7874141/

Abstract

摘要

相似文献

Does the Lectin Complement Pathway Link Kawasaki Disease and SARS-CoV-2?

Front Immunol. 2021 Jan 14;11:604512. doi: 10.3389/fimmu.2020.604512. eCollection 2020.

CD64, CD11a and CD18 leukocytes expression in children with SARS-CoV-2 multisystem inflammatory syndrome versus children with Kawasaki disease: Similar but not the same.

Med Clin (Barc). 2021 Jan 22;156(2):89-91. doi: 10.1016/j.medcli.2020.09.002. Epub 2020 Sep 25.

Characterization of SARS-CoV-2 and common cold coronavirus-specific T-cell responses in MIS-C and Kawasaki disease children.

Eur J Immunol. 2022 Jan;52(1):123-137. doi: 10.1002/eji.202149556. Epub 2021 Oct 27.

Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).

Pediatrics. 2020 Dec;146(6). doi: 10.1542/peds.2020-018242. Epub 2020 Sep 2.

Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease.

Curr Rheumatol Rep. 2021 Jul 3;23(8):58. doi: 10.1007/s11926-021-01028-4.

Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.

Front Immunol. 2021 Feb 26;12:632890. doi: 10.3389/fimmu.2021.632890. eCollection 2021.

Prevalence of paediatric hyperinflammatory conditions in paediatric and adolescent hospitalized COVID-19 patients: a systematic review and meta-analysis.

APMIS. 2022 Feb;130(2):101-110. doi: 10.1111/apm.13199. Epub 2021 Dec 22.

The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection.

Expert Rev Clin Immunol. 2020 Dec;16(12):1205-1215. doi: 10.1080/1744666X.2021.1847643. Epub 2020 Nov 25.

J Clin Invest. 2021 Mar 15;131(6). doi: 10.1172/JCI144554.

The emergence of a new cytokine storm during the COVID-19 pandemic: Multisystem inflammatory syndrome in children.

Kaohsiung J Med Sci. 2021 Mar;37(3):255-256. doi: 10.1002/kjm2.12347. Epub 2021 Jan 5.

引用本文的文献

Plasma Exosomal-Derived SERPINA1 and GNAI2 Downregulation as Potential Diagnostic Biomarkers of Kawasaki Disease with Coronary Artery Aneurysms.

Int J Mol Sci. 2025 Mar 16;26(6):2668. doi: 10.3390/ijms26062668.

[Berberine ameliorates coronary artery endothelial cell injury in Kawasaki disease through complement and coagulation cascades].

Zhongguo Dang Dai Er Ke Za Zhi. 2025 Jan 15;27(1):101-108. doi: 10.7499/j.issn.1008-8830.2406075.

Reduction in ACE2 expression in peripheral blood mononuclear cells during COVID-19 - implications for post COVID-19 conditions.

BMC Infect Dis. 2024 Jul 3;24(1):663. doi: 10.1186/s12879-024-09321-0.

Immunology of Multisystem Inflammatory Syndrome after COVID-19 in Children: A Review of the Current Evidence.

Int J Mol Sci. 2023 Mar 16;24(6):5711. doi: 10.3390/ijms24065711.

Mechanisms of Immune Dysregulation in COVID-19 Are Different From SARS and MERS: A Perspective in Context of Kawasaki Disease and MIS-C.

Front Pediatr. 2022 May 5;10:790273. doi: 10.3389/fped.2022.790273. eCollection 2022.

Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison.

Nat Rev Rheumatol. 2021 Dec;17(12):731-748. doi: 10.1038/s41584-021-00709-9. Epub 2021 Oct 29.

The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery.

iScience. 2021 Nov 19;24(11):103215. doi: 10.1016/j.isci.2021.103215. Epub 2021 Oct 2.

本文引用的文献

The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series.

Br J Dermatol. 2021 Jan;184(1):141-150. doi: 10.1111/bjd.19415. Epub 2020 Sep 15.

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents.

N Engl J Med. 2020 Jul 23;383(4):334-346. doi: 10.1056/NEJMoa2021680. Epub 2020 Jun 29.

Multisystem Inflammatory Syndrome in Children in New York State.

N Engl J Med. 2020 Jul 23;383(4):347-358. doi: 10.1056/NEJMoa2021756. Epub 2020 Jun 29.

Rationale for targeting complement in COVID-19.

EMBO Mol Med. 2020 Aug 7;12(8):e12642. doi: 10.15252/emmm.202012642. Epub 2020 Jul 12.

Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.

JAMA. 2020 Jul 21;324(3):259-269. doi: 10.1001/jama.2020.10369.

Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City.

JAMA. 2020 Jul 21;324(3):294-296. doi: 10.1001/jama.2020.10374.

Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study.

BMJ. 2020 Jun 3;369:m2094. doi: 10.1136/bmj.m2094.

An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.

Lancet. 2020 Jun 6;395(10239):1771-1778. doi: 10.1016/S0140-6736(20)31103-X. Epub 2020 May 13.

Hyperinflammatory shock in children during COVID-19 pandemic.

Lancet. 2020 May 23;395(10237):1607-1608. doi: 10.1016/S0140-6736(20)31094-1. Epub 2020 May 7.

Site-specific glycan analysis of the SARS-CoV-2 spike.

Science. 2020 Jul 17;369(6501):330-333. doi: 10.1126/science.abb9983. Epub 2020 May 4.